• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UbcH10 是癌症发生的主要参与者,也是诊断和治疗的潜在工具。

UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy.

机构信息

Department of Health Sciences, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.

Neuroimaging Unit, Institute of Bioimaging and Molecular Physiology, National Research Council (IBFM-CNR) Viale Europa, 88100 Catanzaro, Italy.

出版信息

Int J Mol Sci. 2020 Mar 17;21(6):2041. doi: 10.3390/ijms21062041.

DOI:10.3390/ijms21062041
PMID:32192022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7139792/
Abstract

Malignant transformation is a multistep process in which several molecular entities become dysregulated and result in dysfunction in the regulation of cell proliferation. In past years, scientists have gradually dissected the pathways involved in the regulation of the cell cycle. The mitotic ubiquitin-conjugating enzymes UbcH10, has been extensively studied since its cloning and characterization and it has been identified as a constantly overexpressed factor in many types of cancer. In this paper, we have reviewed the literature about UbcH10 in human cancer, pointing out the association between its overexpression and exacerbation of cancer phenotype. Moreover, many recalled studied demonstrated how immunohistochemistry or RT-PCR analysis can distinguish normal tissues and benign lesions from malignant neoplasms. In other experimental studies, many of the consequences of UbcH10 overexpression, such as increased proliferation, metastasizing, cancer progression and resistance to anticancer drugs are reversed through gene silencing techniques. In recent years, many authors have defined UbcH10 evaluation in cancer patients as a useful tool for diagnosis and therapy. This opinion is shared by the authors who advertise how it would be useful to start using in clinical practice the notions acquired about this important moleculein the carcinogenesis of many human malignancies.

摘要

恶性转化是一个多步骤的过程,在此过程中,一些分子实体变得失调,导致细胞增殖的调节功能失常。在过去的几年中,科学家们逐渐剖析了参与细胞周期调控的途径。自从 UbcH10 被克隆和鉴定以来,它作为一种在许多类型的癌症中经常过度表达的因子,已经得到了广泛的研究。在本文中,我们回顾了关于 UbcH10 在人类癌症中的文献,指出了其过度表达与癌症表型恶化之间的关联。此外,许多回顾性研究表明,免疫组织化学或 RT-PCR 分析如何能够区分正常组织和良性病变与恶性肿瘤。在其他实验研究中,通过基因沉默技术,UbcH10 过度表达的许多后果,如增加增殖、转移、癌症进展和对抗癌药物的耐药性,都得到了逆转。近年来,许多作者将 UbcH10 在癌症患者中的评估定义为诊断和治疗的有用工具。作者们也认同这一观点,认为在临床实践中开始使用关于这种在许多人类恶性肿瘤发生过程中重要分子的认识是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/7139792/7df4ef011936/ijms-21-02041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/7139792/7df4ef011936/ijms-21-02041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/7139792/7df4ef011936/ijms-21-02041-g001.jpg

相似文献

1
UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy.UbcH10 是癌症发生的主要参与者,也是诊断和治疗的潜在工具。
Int J Mol Sci. 2020 Mar 17;21(6):2041. doi: 10.3390/ijms21062041.
2
Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation.E2 泛素连接酶 UbcH10 的过表达导致染色体错误分离和肿瘤形成。
J Cell Biol. 2010 Jan 11;188(1):83-100. doi: 10.1083/jcb.200906147.
3
Association of clinicopathological features with UbcH10 expression in colorectal cancer.结直肠癌中 UbcH10 表达与临床病理特征的关系。
J Cancer Res Clin Oncol. 2010 Mar;136(3):419-26. doi: 10.1007/s00432-009-0672-7. Epub 2009 Sep 25.
4
Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors.泛素结合酶E2C/UbcH10在星形细胞瘤中的表达。
Brain Res. 2008 Mar 27;1201:161-6. doi: 10.1016/j.brainres.2008.01.037. Epub 2008 Jan 26.
5
UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer.UbcH10 的表达为非小细胞肺癌的预后和治疗提供了一个有用的工具。
J Cancer Res Clin Oncol. 2012 Nov;138(11):1951-61. doi: 10.1007/s00432-012-1275-2. Epub 2012 Jul 4.
6
Clinicopathological relevance of UbcH10 in breast cancer.UbcH10 在乳腺癌中的临床病理相关性。
Cancer Sci. 2009 Feb;100(2):238-48. doi: 10.1111/j.1349-7006.2008.01026.x.
7
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.UbcH10 在人肺癌中的过表达及其与 EGFR 和 p53 突变状态的相关性。
Eur J Cancer. 2013 Mar;49(5):1117-26. doi: 10.1016/j.ejca.2012.09.033. Epub 2012 Oct 24.
8
Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy.免疫组化分析泛素连接酶 UbcH10 在肺癌中的表达:一种用于诊断和治疗的有用工具。
J Histochem Cytochem. 2012 May;60(5):359-65. doi: 10.1369/0022155412439717. Epub 2012 Mar 2.
9
UbcH10 is overexpressed in malignant breast carcinomas.泛素结合酶E2S(UbcH10)在恶性乳腺癌中过表达。
Eur J Cancer. 2007 Dec;43(18):2729-35. doi: 10.1016/j.ejca.2007.09.003. Epub 2007 Oct 22.
10
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.UbcH10的表达可预测结直肠癌患者的预后及对抗肿瘤治疗的敏感性。
Mol Carcinog. 2016 May;55(5):793-807. doi: 10.1002/mc.22322. Epub 2015 Apr 27.

引用本文的文献

1
Prognostic Value of Systemic Inflammatory Markers in Malignant Tumors of Minor Salivary Glands: A Retrospective Analysis of a Single Center.小涎腺恶性肿瘤中全身炎症标志物的预后价值:单中心回顾性分析
Cancers (Basel). 2025 Apr 21;17(8):1373. doi: 10.3390/cancers17081373.
2
The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response.肺癌细胞中UbcH10、p53和表皮生长因子受体(EGFR)之间的相互联系及其与治疗反应的关系
Genes (Basel). 2025 Mar 30;16(4):404. doi: 10.3390/genes16040404.
3
Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.

本文引用的文献

1
Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.hsa-miR661-3p 对体内外非小细胞肺癌的抗肿瘤作用。
Oncol Rep. 2019 May;41(5):2987-2996. doi: 10.3892/or.2019.7084. Epub 2019 Mar 21.
2
UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability.UBE2C是具有染色体不稳定的肠型胃癌的潜在生物标志物。
Front Pharmacol. 2018 Aug 2;9:847. doi: 10.3389/fphar.2018.00847. eCollection 2018.
3
Role of Macrophages in Brain Tumor Growth and Progression.巨噬细胞在脑肿瘤生长和进展中的作用。
泛素及类泛素修饰在癌症治疗中的功能、机制与药物发现及多组学分析
Acta Pharm Sin B. 2023 Nov;13(11):4341-4372. doi: 10.1016/j.apsb.2023.07.019. Epub 2023 Jul 22.
4
Role of UBE2C in Brain Cancer Invasion and Dissemination.UBE2C 在脑癌侵袭和转移中的作用。
Int J Mol Sci. 2023 Oct 31;24(21):15792. doi: 10.3390/ijms242115792.
5
Combined Inhibition of and Reduce Cell Proliferation and Arrest Cell Cycle by Affecting in Pan-Cancer.在泛癌中,通过影响 ,联合抑制 和 减少细胞增殖并使细胞周期停滞。
Int J Mol Sci. 2023 Oct 27;24(21):15658. doi: 10.3390/ijms242115658.
6
Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency.鉴定颗粒细胞转录组特征及 UBE2C 在卵巢早衰发病机制中的可能作用。
J Ovarian Res. 2023 Oct 17;16(1):203. doi: 10.1186/s13048-023-01266-3.
7
Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.UBE2C 在子宫内膜癌中的异常表达及其与上皮间质转化的关系。
Medicine (Baltimore). 2023 May 19;102(20):e33834. doi: 10.1097/MD.0000000000033834.
8
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease.UBE2C促进软脑膜播散,是脑转移瘤疾病的一个治疗靶点。
Neurooncol Adv. 2023 Apr 28;5(1):vdad048. doi: 10.1093/noajnl/vdad048. eCollection 2023 Jan-Dec.
9
Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma.Emi1、UBCH10 和 CyclinB1 在食管鳞癌中的表达意义。
Pathol Oncol Res. 2023 Apr 24;29:1611081. doi: 10.3389/pore.2023.1611081. eCollection 2023.
10
UBE2S and UBE2C confer a poor prognosis to breast cancer downregulation of Numb.UBE2S和UBE2C通过下调Numb导致乳腺癌预后不良。
Front Oncol. 2023 Feb 14;13:992233. doi: 10.3389/fonc.2023.992233. eCollection 2023.
Int J Mol Sci. 2018 Mar 27;19(4):1005. doi: 10.3390/ijms19041005.
4
YAP-associated chromosomal instability and cholangiocarcinoma in mice.YAP相关的染色体不稳定性与小鼠胆管癌
Oncotarget. 2017 Dec 22;9(5):5892-5905. doi: 10.18632/oncotarget.23638. eCollection 2018 Jan 19.
5
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.用于癌症治疗的泛素激活酶小分子抑制剂。
Nat Med. 2018 Feb;24(2):186-193. doi: 10.1038/nm.4474. Epub 2018 Jan 15.
6
Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.利用多靶点浮力免疫微泡分离乳腺癌循环肿瘤细胞。
Colloids Surf B Biointerfaces. 2018 Jan 1;161:200-209. doi: 10.1016/j.colsurfb.2017.10.060. Epub 2017 Oct 23.
7
RIZ1 negatively regulates ubiquitin-conjugating enzyme E2C/UbcH10 via targeting c-Myc in meningioma.在脑膜瘤中,RIZ1通过靶向c-Myc负向调节泛素结合酶E2C/UbcH10。
Am J Transl Res. 2017 May 15;9(5):2645-2655. eCollection 2017.
8
hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10.hsa-miR-631通过抑制UbcH10使硼替佐米耐药的多发性骨髓瘤细胞系重新敏感。
Oncol Rep. 2017 Feb;37(2):961-968. doi: 10.3892/or.2016.5318. Epub 2016 Dec 14.
9
UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.尿液中的泛素结合酶E2C无细胞RNA能够区分膀胱癌和血尿。
Oncotarget. 2016 Sep 6;7(36):58193-58202. doi: 10.18632/oncotarget.11277.
10
Non-invasive real-time biopsy of intracranial lesions using short time expanded circulating tumor cells on glass slide: report of two cases.利用玻片上短时间扩增的循环肿瘤细胞对颅内病变进行非侵入性实时活检:两例报告
BMC Neurol. 2016 Aug 8;16:127. doi: 10.1186/s12883-016-0652-x.